Share on (60818670930):
Product name | Vonoprazan fumarate |
CAS NO. | 1260141-27-2 |
Synonyms | Vonoprazan |
Category | Pharmaceutical Raw Materials,Active Pharmaceutical Ingredients,Bulk Drugs,Fine Chemicals. |
Standard | purity:>99% |
Appearance | Vonoprazan fumarate powder |
Shelf life | 2 years |
Usage | Vonoprazan fumarate shows strong and sustainable acid secretion inhibitory effects as well as demonstrate efficacy in early termination by inhibiting the binding of potassium ion (K+) to H+, K+-ATPase (proton pump) in the final step of gastric acid secretion in gastric parietal cells. |
Storage | Vonoprazan fumarate should be stored in a well-closed container at low temperature, keep away from moisture, heat and light. |

Shipping Way
Professional and Various shipping way
Product name | Cas No. | Standard | Certifications |
Carboplatin | 41575-94-4 | EP8/USP38 | |
Cisplatin | 15663-27-1 | EP8/USP38 | |
Oxaliplatin | 61825-94-3 | EP8/USP38 | CEP PMDA DMF |
Capecitabine | 154361-50-9 | EP8/USP38 | EU CEP |
Pemetrexed Disodium hemipenta hydrate | 357166-30-4 | In-house | |
Pemetrexed disodium heptahydrate | 357166-29-1 | EP8 | EU CEP |
AZD-9291 | 1421373-65-0 | In-house | |
Lapatinib | 231277-92-2 | In-house | |
Lapatinib ditosylate | 388082-77-7/388082-78-8 | In-house | |
Docetaxel | 114977-28-5 | In-house | |
Dasatinib | 302962-49-8 | In-house | |
Dasatinib Monohydrate | 863127-77-9 | In-house | |
1-methylcyclopropanecarboxylic acid | 6914-76-7 | In-house | |
Lenalidomide | 191732-72-6 | In-house | |
Bortezomib | 179324-69-7 | In-house | |
Lenvatinib | 417716-92-8 | In-house | |
Ibrutinib | 936563-96-1 | In-house | |
Palbociclib | 571190-30-2 | In-house | |
Gefitinib | 184475-35-2 | In-house | |
Tegafur | 17902-23-7 | CP2010/JP16 | |
Cyclophosphamide monohydrate | 6055-19-2 | EP8/USP38 | |
Zoledronic acid hydrate | 165800-06-6 | In-house | |
Aprepitant | 170729-80-3 | In-house | |
Fosaprepitant dimeglumine | 265121-04-8 | In-house | |
Miriplatin | 141977-79-9 | In-house | |
Sunitinib | 557795-19-4 | In-house |
Wuhan Vanz Pharm Inc. was founded in 2011 and We are comprehensive enterprise with business range covering R&D, production and sales of APIs, pharmaceutical intermediates, plant extracts, all kinds of organic intermediates and so on. We bought 14,000 square meters production base in Panhu Industrial Park, established several pharmaceutical synthesis production lines, and continually expands our production capacity.
We have a professional research team of highly qualified and experienced chemists. most of our R&D team are Master and higher. With their effort, we quickly transfer the science fruit into production. Our manufacturing site is located in Wuhan which is equipped with 100L~5000L reactors; we can offer one-stop services from R&D to commercial production. (Normal reaction/ High-pressure reaction/ Catalytic reaction/ Low-Temperature reaction).



New products from manufacturers at wholesale prices